This study for the first time proved the therapeutic effects of MV on follicle development and ovulation in young-adult rats (about 10 weeks old) with PCOS in vivo by upregulating the expression of LDHA, HK2 and PKM2 to improve the energy supply of follicle development. Here, HK2 is linked to polycystic ovary syndrome.